How REZDIFFRA Is Transforming the NASH Treatment Landscape

agregó una foto Health

2026-08-30 11:14:36 -

For decades, doctors treating fatty liver disease had no approved medicine to offer — only advice about diet, exercise, and watchful waiting. That changed in March 2024, when the FDA approved REZDIFFRA (resmetirom), becoming the first drug ever cleared specifically for nonalcoholic steatohepatitis (NASH), also known by its newer clinical name, MASH (metabolic dysfunction-associated...

0 Commentarios 0 Acciones 1K Views 0 Vista previa